title: Breast cancer screening for women aged 40-49 years: screening may not be the benign process usually thought.
authors.forename: M
authors.initials: M
authors.lastname: Retsky
authors.forename: R
authors.initials: R
authors.lastname: Demicheli
authors.forename: W
authors.initials: W
authors.lastname: Hrushesky
mesh_terms: D000328:Adult; D001706:Biopsy; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000401:mortality / Q000473:pathology / Q000601:surgery; D002170:Canada; D015975:Consensus Development Conferences, NIH as Topic; D018450:Disease Progression; D016228:Endothelial Growth Factors / Q000097:blood; D005260:Female; D006133:Growth Substances / Q000378:metabolism; D006801:Humans; D008207:Lymphatic Metastasis; D008222:Lymphokines / Q000097:blood; D008327:Mammography; D008403:Mass Screening / Q000009:adverse effects*; D008408:Mastectomy / Q000009:adverse effects*; D008597:Menstrual Cycle; D008875:Middle Aged; D008954:Models, Biological; D009389:Neovascularization, Pathologic / Q000209:etiology*; D017697:Premenopause; D011374:Progesterone / Q000097:blood; D016032:Randomized Controlled Trials as Topic; D014481:United States; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
chemical_list: D016228:Endothelial Growth Factors; D006133:Growth Substances; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D011374:Progesterone